{"title":"感染性疾病化疗的最新进展:急诊科从业人员回顾2020。","authors":"Boris Garber, Jonathan Glauser","doi":"10.1007/s40138-020-00218-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>We discuss and review new antimicrobials for treatment of bacterial, viral, fungal, and parasitic infections with indications, contraindications, and side effects for each. We will also review new information and indications on older agents that are relevant to clinical practice. Many of them may be unfamiliar to Emergency Physicians given their newness and at times hospital restrictions on their use. We also review some new promising agents that are not yet in the clinical pipeline.</p><p><strong>Recent findings: </strong>As new antibiotics become available for clinicians to use, new information becomes available with respect to the drugs' indications, efficacy, pathogen resistance, drug-drug interactions, and side effects.</p><p><strong>Summary: </strong>This article provides Emergency Department clinicians with a useful summary with new information on antibiotic use and recent research into agents which may become available.</p>","PeriodicalId":43451,"journal":{"name":"Current Emergency and Hospital Medicine Reports","volume":"8 3","pages":"116-121"},"PeriodicalIF":1.4000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40138-020-00218-1","citationCount":"3","resultStr":"{\"title\":\"Recent Developments in Infectious Disease Chemotherapy: Review for Emergency Department Practitioners 2020.\",\"authors\":\"Boris Garber, Jonathan Glauser\",\"doi\":\"10.1007/s40138-020-00218-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose of review: </strong>We discuss and review new antimicrobials for treatment of bacterial, viral, fungal, and parasitic infections with indications, contraindications, and side effects for each. We will also review new information and indications on older agents that are relevant to clinical practice. Many of them may be unfamiliar to Emergency Physicians given their newness and at times hospital restrictions on their use. We also review some new promising agents that are not yet in the clinical pipeline.</p><p><strong>Recent findings: </strong>As new antibiotics become available for clinicians to use, new information becomes available with respect to the drugs' indications, efficacy, pathogen resistance, drug-drug interactions, and side effects.</p><p><strong>Summary: </strong>This article provides Emergency Department clinicians with a useful summary with new information on antibiotic use and recent research into agents which may become available.</p>\",\"PeriodicalId\":43451,\"journal\":{\"name\":\"Current Emergency and Hospital Medicine Reports\",\"volume\":\"8 3\",\"pages\":\"116-121\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s40138-020-00218-1\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Emergency and Hospital Medicine Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40138-020-00218-1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/6/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"EMERGENCY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Emergency and Hospital Medicine Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40138-020-00218-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/6/16 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"EMERGENCY MEDICINE","Score":null,"Total":0}
Recent Developments in Infectious Disease Chemotherapy: Review for Emergency Department Practitioners 2020.
Purpose of review: We discuss and review new antimicrobials for treatment of bacterial, viral, fungal, and parasitic infections with indications, contraindications, and side effects for each. We will also review new information and indications on older agents that are relevant to clinical practice. Many of them may be unfamiliar to Emergency Physicians given their newness and at times hospital restrictions on their use. We also review some new promising agents that are not yet in the clinical pipeline.
Recent findings: As new antibiotics become available for clinicians to use, new information becomes available with respect to the drugs' indications, efficacy, pathogen resistance, drug-drug interactions, and side effects.
Summary: This article provides Emergency Department clinicians with a useful summary with new information on antibiotic use and recent research into agents which may become available.
期刊介绍：
This journal aims to offer expert review articles on the most significant recent developments in emergency and hospital medicine, with particular emphasis on the transition of patient care from the emergency department to the hospitalist service. By providing clear, insightful, balanced contributions, the journal intends to serve 1) those who provide immediate medical attention to patients with acute injuries or conditions in emergency departments and emergency medical service settings, and 2) hospitalists who deliver comprehensive medical care in collaboration with physicians and other health care personnel responsible for hospitalized patients. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas across the field. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An Editorial Board of more than 20 internationally diverse members reviews the annual table of contents, ensures that topics include emerging research, and suggests topics of special importance to their country/region. Topics covered may include acute coronary syndrome; chronic obstructive pulmonary disease; community-acquired infections; diabetes and metabolic disease; heart failure; hospital-acquired infections; pharmacology of acute care; shared practice and economic issues; and thrombosis.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
